Literature DB >> 7609625

Evidence for the presence of beta 3-adrenergic receptor mRNA in the human brain.

M Rodriguez1, C Carillon, A Coquerel, G Le Fur, P Ferrara, D Caput, D Shire.   

Abstract

The beta 3-adrenergic receptor (AR) is widely distributed in peripheral tissues, but up to now it has not been detected in the central nervous system. By using the polymerase chain reaction (PCR) technique, we found the beta 3-AR mRNA to be present in all the regions of the human brain we investigated. The quantities found were very low compared to those of the beta 1-AR and beta 2-AR mRNAs, being hardly detectable in adult brain. In contrast, the brain of very young infants contained about 100 times more beta 3-AR mRNA than the adult brain, whereas the amounts of beta 1-AR and beta 2-AR transcripts were essentially the same. In addition, using PCR we have cloned a central beta 3-AR coding region from a human frontal cortex cDNA library and have found it to be identical to the corresponding peripheral sequence.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7609625     DOI: 10.1016/0169-328x(94)00274-i

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  13 in total

1.  β(3) Receptors: Role in Cardiometabolic Disorders.

Authors:  Shraddha V Bhadada; Bhoomika M Patel; Anita A Mehta; Ramesh K Goyal
Journal:  Ther Adv Endocrinol Metab       Date:  2011-04       Impact factor: 3.565

Review 2.  Reflections on glycogen and β-amyloid: why does glycogenolytic β2-adrenoceptor stimulation not rescue memory after β-amyloid?

Authors:  Marie Gibbs
Journal:  Metab Brain Dis       Date:  2014-05-09       Impact factor: 3.584

3.  Expression of beta 3-adrenoceptor mRNA in rat brain.

Authors:  R J Summers; M Papaioannou; S Harris; B A Evans
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

4.  Effect of β3 adrenoceptor activation in the basolateral amygdala on ethanol seeking behaviors.

Authors:  T R Butler; A M Chappell; J L Weiner
Journal:  Psychopharmacology (Berl)       Date:  2013-08-17       Impact factor: 4.530

5.  Lateral paracapsular GABAergic synapses in the basolateral amygdala contribute to the anxiolytic effects of beta 3 adrenoceptor activation.

Authors:  Yuval Silberman; Olusegun J Ariwodola; Ann M Chappell; Jordan T Yorgason; Jeff L Weiner
Journal:  Neuropsychopharmacology       Date:  2010-04-21       Impact factor: 7.853

Review 6.  Corticotropin releasing factor and norepinephrine related circuitry changes in the bed nucleus of the stria terminalis in stress and alcohol and substance use disorders.

Authors:  Angela E Snyder; Yuval Silberman
Journal:  Neuropharmacology       Date:  2021-10-06       Impact factor: 5.250

Review 7.  What do we know and not know about mirabegron, a novel β3 agonist, in the treatment of overactive bladder?

Authors:  Romain Caremel; Oleg Loutochin; Jacques Corcos
Journal:  Int Urogynecol J       Date:  2013-08-07       Impact factor: 2.894

8.  Cerebral non-oxidative carbohydrate consumption in humans driven by adrenaline.

Authors:  Thomas S Seifert; Patrice Brassard; Thomas B Jørgensen; Ahmad J Hamada; Peter Rasmussen; Bjørn Quistorff; Niels H Secher; Henning B Nielsen
Journal:  J Physiol       Date:  2008-11-17       Impact factor: 5.182

9.  2D-QSAR and 3D-QSAR/CoMSIA Studies on a Series of (R)-2-((2-(1H-Indol-2-yl)ethyl)amino)-1-Phenylethan-1-ol with Human β₃-Adrenergic Activity.

Authors:  Gastón Apablaza; Luisa Montoya; Cesar Morales-Verdejo; Marco Mellado; Mauricio Cuellar; Carlos F Lagos; Jorge Soto-Delgado; Hery Chung; Carlos David Pessoa-Mahana; Jaime Mella
Journal:  Molecules       Date:  2017-03-05       Impact factor: 4.411

10.  Structure-Activity Relationships Based on 3D-QSAR CoMFA/CoMSIA and Design of Aryloxypropanol-Amine Agonists with Selectivity for the Human β3-Adrenergic Receptor and Anti-Obesity and Anti-Diabetic Profiles.

Authors:  Marcos Lorca; Cesar Morales-Verdejo; David Vásquez-Velásquez; Juan Andrades-Lagos; Javier Campanini-Salinas; Jorge Soto-Delgado; Gonzalo Recabarren-Gajardo; Jaime Mella
Journal:  Molecules       Date:  2018-05-16       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.